Learn more and donate: http://www.maps.org/
Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source
Learn more and donate: http://www.maps.org/
James Fadiman, PhD, and Sophia Korb, PhD
Microdosing: The Phenomenon, Research Results, and Startling Surprises
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source
Learn more and donate: http://www.maps.org/
Franz Vollenweider, MD
Psychedelic 5HT2A Receptor Agonists
Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source
Learn more and donate: http://www.maps.org/
Paul Glue, MD, FRC Psych
Ibogaine and Opioid Withdrawal: Does it Work and Is it Safe?
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source